← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2011Last known activity
Mar 1, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 5 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT07303283CollaboratorPhase 2Mar 1, 2026
- NCT07312656CollaboratorPhase 2Jan 31, 2026
- NCT05340270CollaboratorPhase 2Aug 1, 2022
- NCT02407366Study chairPhase 2Dec 1, 2014
- NCT01479504CollaboratorPhase 3Nov 1, 2011
Details
- Last known activity
- Mar 1, 2026